Bikam Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Bikam Pharmaceuticals Ownership

Who owns Bikam Pharmaceuticals?

Bikam Pharmaceuticals is owned by Shire. It was acquired on July 9, 2014.

Was Bikam Pharmaceuticals formerly PE-backed?

Yes. Bikam Pharmaceuticals was formerly owned by 1 private investor.

Bikam Pharmaceuticals Business Overview

Where is Bikam Pharmaceuticals headquartered?

Bikam Pharmaceuticals is headquartered in Cambridge, Massachusetts.

What sector is Bikam Pharmaceuticals in?

Bikam Pharmaceuticals is a life science company.

Life Science M&A Summary in 2014

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.

Join Mergr to view all 237 acquisitions of life science companies in 2014, including 22 acquisitions by private equity firms, and 215 by strategics.

Bikam Pharmaceuticals

Bikam Pharmaceuticals

55 Cambridge Parkway Suite 301,
Cambridge, Massachusetts 02142
United States,
www.bikampharmaceuticals.com

Bikam Pharmaceuticals is a drug discovery company focused on developing novel therapies for diseases of the eye with exceptionally high unmet medical need. Bikam Pharmaceuticals is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 206,305
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.